DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer
Position
Chief Medical Officer
Company
DiaMedica Therapeutics
MinneapolisBiotechnologyHealth CareTherapeuticsBiopharmaDescription
DiaMedica Therapeutics Inc. appoints Lorianne Masuoka, M.D. as Chief Medical Officer.
Quick answer
DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer (January 22, 2024). DiaMedica Therapeutics is based in Minneapolis, Minnesota, United States.
- Who is the new Chief Medical Officer at DiaMedica Therapeutics?
- DiaMedica Therapeutics named Lorianne Masuoka Chief Medical Officer, announced January 22, 2024.
- What did DiaMedica Therapeutics announce on January 22, 2024?
- DiaMedica Therapeutics Inc. appoints Lorianne Masuoka, M.D. as Chief Medical Officer.
- What does DiaMedica Therapeutics do?
- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), is a clinical-stage biopharmaceutical company that is focused on developing novel treatments where there is significant unmet clinical need or where no current therapies are...
- Where is DiaMedica Therapeutics based?
- DiaMedica Therapeutics is based in Minneapolis, Minnesota, United States.
- Which similar companies made leadership changes around the same time?
- Alkeus Pharmaceuticals (January 23, 2024), NeoImmuneTech (January 15, 2024), Acadia Pharmaceuticals (January 31, 2024) and Corvus Pharmaceuticals, Inc. (February 6, 2024) also announced leadership changes within 45 days of DiaMedica Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Alkeus Pharmaceuticals Appoints Seemi Khan, M.D., Chief Medical Officer (January 23, 2024)
- NeoImmuneTech Welcomes a New President for its Development and Business (January 15, 2024)
- Acadia Announces Additions to Executive Team (January 31, 2024)
- Corvus Pharmaceuticals Appoints Jeffrey Arcara as Chief Business Officer (February 6, 2024)
- Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating Officer (February 7, 2024)
- Aligos Therapeutics Strengthens Finance Leadership Team with Two New Appointments (February 13, 2024)
Who to call at DiaMedica Therapeutics, and when
A new leader at DiaMedica Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day DiaMedica Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at DiaMedica Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at DiaMedica Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment DiaMedica Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
DiaMedica Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.